KIF18A inhibitor GH2616
Term · Oncology and biomedicine · MLC-T-ONC-014642
An orally bioavailable inhibitor of the human kinesin-like protein KIF18A, with potential antineoplastic activity. Upon oral administration, KIF18A inhibitor GH2616 selectively binds to and inhibits the activity of KIF18A. This may result in multipolar cell division and inhibit tumor cell proliferation. KIF18A, a mitotic kinesin-8 motor protein, plays an important role in the regulation of chromosome positioning during cell division and is overexpressed in certain cancers. Certain cancer cells with chromosomal instability (CIN) features depend on KIF18A activity for bipolar spindle integrity and cell proliferation.
| Identifier | MLC-T-ONC-014642 |
|---|---|
| Field | Oncology and biomedicine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-014642",
"term": "KIF18A inhibitor GH2616",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable inhibitor of the human kinesin-like protein KIF18A, with potential antineoplastic activity. Upon oral administration, KIF18A inhibitor GH2616 selectively binds to and inhibits the activity of KIF18A. This may result in multipolar cell division and inhibit tumor cell proliferation. KIF18A, a mitotic kinesin-8 motor protein, plays an important role in the regulation of chromosome positioning during cell division and is overexpressed in certain cancers. Certain cancer cells with chromosomal instability (CIN) features depend on KIF18A activity for bipolar spindle integrity and cell proliferation.",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/kif18a-inhibitor-gh2616/"
}
Record 9,773 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.